Prof. Fairclough and I got into a great discussion about practical BCIs on the sidelines of the Neuradaptive Technology Conference in Liverpool in the summer of 2019. Here’s the podcast.
Here’s a fun debate in which Sean Speer and I took on Armine Yalnizian and Linda McQuaig on the topic of whether billionaires should be taxed out of existence. It aired in January 2020 on TVO’s The Agenda with Steve Paikin.
Wealth inequality is not about billionaires. It’s about your house.
I had some comments on non-compete clauses in Christine Dobby’s excellent Globe & Mail article, Sign here: Why the increasing use of non-compete clauses is bad for employees, and the economy.
Here’s a discussion I had with Daniel Lee, the compelling founder of OMD Ventures.
No. It’s not all nonsense, but some of it definitely is. This article from Diana Kwon does a good job of discussing some of the industry’s challenges (with a quote from yours truly).
Chris Aimone and were fortunate to be given the opportunity to present from the Digital Health Summit stage at CES 2019. Here’s what we said.
I really enjoyed giving this talk, on neurotechnology as a career and how to move from academic science into business, at BrainHack Toronto 2018.
In putting together the article above, Christina Farr was gracious enough to listen to my theory about Apple’s not-so-secret plan that explains why there’s suddenly an ECG in the Apple Watch 4. What surprised me the most is that everyone focused on it as an ECG, including all of the tech and digital health press,
We will soon reach a milestone: sometime in the not too distant future, a consumer neurotechnology will sell millions of units. Not long after, a neurotechnology will sell millions of units per year, and so on. This is NOT fiction. This is where we’re going right now.
(These are my remarks to the neurotechnology workshop of the OECD Working Group on Emerging Technologies.)